前药
细胞外
细胞内
免疫疗法
细胞外小泡
材料科学
癌症研究
医学
药理学
化学
免疫系统
免疫学
生物化学
细胞生物学
生物
作者
Yongjuan Li,Yongjian Cao,Ke Ma,Rujian Ma,Mengzhe Zhang,Yichen Guo,Haiwei Song,Nannan Sun,Zhenzhong Zhang,Weijing Yang
标识
DOI:10.1002/adhm.202303568
摘要
Abstract High reactive oxygen species (ROS) levels in tumor microenvironment (TME) will impair both immunogenic cell death (ICD) efficacy and T cell activity. Furthermore, tumor escapes immunosurveillance via programmed death‐1/programmed death ligand‐1 (PD‐L1) signal, and the insufficient intracellular hydrogen peroxide will weaken ferroptosis efficacy. To tackle the above issues, we construct a glutathione (GSH)/ROS/pH triple‐responsive prodrug nanomedicine that encapsulates Fe 2 O 3 nanoparticle via electrostatic interaction for magnetic resonance imaging (MRI)‐guided multi‐mode theranostics with chemotherapy/ferroptosis /immunotherapy. The diselenide bond consumes ROS in TME to increase T cells and ICD efficacy, the cleavage of which facilitates PD‐L1 antagonist D peptide release to block immune checkpoint. After intracellular internalization, Fe 2 O 3 nanoparticle is released in the acidic endosome for MRI simultaneously with lipid peroxides generation for tumor ferroptosis. DOX is cleaved from polymers in the condition of high intracellular GSH level accompanied by tumor ICD, which simultaneously potentiates ferroptosis by NADPH oxidase mediated H 2 O 2 self‐generation. In vivo results indicate that the nanoplatform strengthens tumor ICD, induces cytotoxic T lymphocytes proliferation, inhibits 4T1 tumor regression and metastasis, and prolongs survival median. In all, we propose a new strategy in strengthening ICD and T cells activity cascade with ferroptosis as well as immune checkpoint blockade for effective tumor immunotherapy. This article is protected by copyright. All rights reserved
科研通智能强力驱动
Strongly Powered by AbleSci AI